LTC PROPERTIES REIT INC (LTC)
Sector: Real Estate
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Real Estate
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LTC
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LTC | Director, Center for Personalized Medicine, Children’s Hospital, Los Angeles; Chair | 81 | ["Executive and director experience with health care companies","Background in the health care industry","Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles since July 2010","Former Chairman of the Department of Pathology and Laboratory Medicine at Children’s Hospital Los Angeles","Professor of pathology and pediatrics at the University of Southern California Keck School of Medicine since 1988","Board member of Avrok Biosciences","Board member of NanoValent Pharmaceuticals","Founder of InteroOme"] | ["AC","CC","IC","NCGC","SCRC","Audit Committee","Investment Committee","Sustainability and Corporate Responsibility Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Director since 2000 Age: 81 Reason for nomination: Dr. Triche s current and past executive and director experience with other health care companies, and his background in the health care industry, qualify him to serve on the Board of Directors of LTC. Background : Dr. Triche has been director of the Center for Personalized Medicine at Children s Hospital Los Angeles since July 2010, and previously was Chairman of the Department of Pathology and Laboratory Medicine at Children s Hospital Los Angeles. He has also been a professor of pathology and pediatrics at the University of Southern California Keck School of Medicine in Los Angeles since 1988. Other Directorships : Dr. Triche is on the Board of Directors of Avrok Biosciences, a private biotechnology company, NanoValent Pharmaceuticals, a private nanotechnology company and InteroOme, a private company he founded.